{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:38:18Z","timestamp":1770140298999,"version":"3.49.0"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study reports cases of systemic-onset juvenile idiopathic arthritis (sJIA) who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) at our center and reviews published outcomes of allo-HSCT in sJIA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We present a case report of two patients with sJIA who underwent allo-HSCT at a tertiary pediatric hospital. Each patient\u2019s disease course and allo-HSCT protocol\/outcome are described. Outcomes of published cases of allo-HSCT in sJIA were compared to our experience.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Two patients with sJIA had allo-HSCT. Both failed multiple lines of disease-modifying anti-rheumatic drugs and experienced severe disease\/treatment-related complications. Despite post-HSCT complications, both recovered without sequelae. Five years post-HSCT, patient 1 is in complete remission (CR) and is off medications. Patient 2 was in CR until 11\u2009months post-HSCT after which he developed three disease flares. At 4\u2009years post-HSCT he is currently in CR on Adalimumab monotherapy. Engraftment was excellent with a donor chimerism of 100% for patient 1 and 93% for patient 2. In the literature, the outcome of allo-HSCT is reported in 13 sJIA patients. When merging those with our 2 patients, 1\/15 patients died and 13\/14 achieved CR, of which 12 are off medications (median [range] follow-up: 2.2 [0.2\u20137.0] years). Extended follow-up data on 11 of the 13 reported sJIA patients showed that an additional 3 patients flared at 3, 4, and 10\u2009years post-HSCT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We report two patients with severe\/refractory sJIA who underwent successful allo-HSCT and achieved CR. Allo-HSCT is a potential curative option for severe\/refractory sJIA. It should be considered only after failure of conventional sJIA treatments and when an HLA-matched donor is available in order to lower transplant-related mortality. The outcomes of reported sJIA patients who received allo-HSCT are encouraging but long-term follow-up data are needed to better characterized the risk\u2013benefit ratio of this procedure.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1275927","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:34:51Z","timestamp":1697441691000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case report: Success of allogeneic hematopoietic stem cell transplantation for refractory systemic-onset juvenile idiopathic arthritis"],"prefix":"10.3389","volume":"10","author":[{"given":"Camille","family":"Beaufils","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Proulx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annaliesse","family":"Blincoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Teira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique","family":"Bittencourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Cellot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Duval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Paule","family":"Morin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Jacques","family":"De Bruycker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Couture","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Decaluwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niina","family":"Kleiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramy","family":"El-Jalbout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien","family":"Touzot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elie","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Barsalou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jpeds.2016.06.056","article-title":"Diagnosis and treatment of systemic juvenile idiopathic arthritis","volume":"177","author":"Shenoi","year":"2016","journal-title":"J Pediatr"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1136\/ard.2003.017798","article-title":"Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity","volume":"63","author":"De Kleer","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1365-2141.2012.09122.x","article-title":"Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009","volume":"157","author":"Snowden","year":"2012","journal-title":"Br J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/BOR.0b013e32835264f4","article-title":"Changing winds in refractory autoimmune disease in children: clearing the road for tolerance with cellular therapies","volume":"24","author":"Swart","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.3389\/fimmu.2019.01570","article-title":"Allogeneic HSCT for autoimmune diseases: a retrospective study from the EBMT ADWP, IEWP, and PDWP working parties","volume":"10","author":"Greco","year":"2019","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.bjhh.2014.07.003","article-title":"Hemophagocytic lymphohistiocytosis: a case series of a Brazilian institution","volume":"36","author":"Ferreira","year":"2014","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00005-014-0279-9","article-title":"Hematopoietic stem cell transplantation in children with autoimmune connective tissue diseases","volume":"62","author":"Witkowska","year":"2014","journal-title":"Arch Immunol Ther Exp"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/ar2486","article-title":"Stem cell transplantation for rheumatic autoimmune diseases","volume":"10","author":"Hugle","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/ar102","article-title":"Immune ablation and stem-cell therapy in autoimmune disease. Clinical experience","volume":"2","author":"Tyndall","year":"2000","journal-title":"Arthritis Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1182\/bloodadvances.2017014449","article-title":"Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis","volume":"2","author":"Silva","year":"2018","journal-title":"Blood Adv"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12969-021-00523-3","article-title":"Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis","volume":"19","author":"Morelle","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1123104","DOI":"10.3389\/fped.2023.1123104","article-title":"Case report: Emapalumab for active disease control prior to hematopoietic stem cell transplantation in refractory systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome","volume":"11","author":"Chellapandian","year":"2023","journal-title":"Front Pediatr"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1201\/9781315151366-57","article-title":"Haematopoietic stem cell transplantation for juvenile idiopathic arthritis","volume-title":"Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases","author":"Abinun","year":"2021"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1002\/art.22656","article-title":"Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial","volume":"56","author":"Brinkman","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.1016\/S2352-3026(19)30158-9","article-title":"Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis","volume":"6","author":"Shouval","year":"2019","journal-title":"Lancet Haematol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/bmt.2013.50","article-title":"Matched unrelated or matched sibling donors result in comparable outcomes after non-myeloablative HSCT in patients with AML or MDS","volume":"48","author":"Robin","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.bbmt.2012.01.007","article-title":"Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia","volume":"18","author":"Zhang","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1182\/blood-2011-09-381699","article-title":"Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia","volume":"119","author":"Saber","year":"2012","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3389\/fimmu.2020.01791","article-title":"Chimerism in the realm of hematopoietic stem cell transplantation for non-malignant disorders-a perspective","volume":"11","author":"Zimmerman","year":"2020","journal-title":"Front Immunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"951535","DOI":"10.3389\/fimmu.2022.951535","article-title":"Pathogenic roles and diagnostic utility of interleukin-18 in autoinflammatory diseases","volume":"13","author":"Shimizu","year":"2022","journal-title":"Front Immunol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1275927\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:34:53Z","timestamp":1697441693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1275927\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":20,"alternative-id":["10.3389\/fmed.2023.1275927"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1275927","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,16]]},"article-number":"1275927"}}